Global Haemophilus Influenzae Type B Vaccine Market Insights, Forecast to 2028

Global Haemophilus Influenzae Type B Vaccine Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Haemophilus Influenzae Type B Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liquid Monovalent HIB
1.2.3 Liquid Combination HIB
1.2.4 Lyophilized Monovalent HIB
1.2.5 Lyophilized Combination HIB
1.3 Market by Application
1.3.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Research Institutions
1.3.4 Pharmaceutical and Biotechnology Companies
1.3.5 Academic Institutions
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Haemophilus Influenzae Type B Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Haemophilus Influenzae Type B Vaccine Sales by Region
2.4.1 Global Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Haemophilus Influenzae Type B Vaccine by Region (2023-2028)
2.5 Global Haemophilus Influenzae Type B Vaccine Revenue by Region
2.5.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2022)
2.5.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers
3.1.1 Global Top Haemophilus Influenzae Type B Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Haemophilus Influenzae Type B Vaccine in 2021
3.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers
3.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Haemophilus Influenzae Type B Vaccine Revenue in 2021
3.3 Global Haemophilus Influenzae Type B Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Haemophilus Influenzae Type B Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type
4.1.1 Global Haemophilus Influenzae Type B Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type
4.2.1 Global Haemophilus Influenzae Type B Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Haemophilus Influenzae Type B Vaccine Price by Type
4.3.1 Global Haemophilus Influenzae Type B Vaccine Price by Type (2017-2022)
4.3.2 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application
5.1.1 Global Haemophilus Influenzae Type B Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application
5.2.1 Global Haemophilus Influenzae Type B Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Haemophilus Influenzae Type B Vaccine Price by Application
5.3.1 Global Haemophilus Influenzae Type B Vaccine Price by Application (2017-2022)
5.3.2 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Haemophilus Influenzae Type B Vaccine Market Size by Type
6.1.1 North America Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028)
6.1.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2028)
6.2 North America Haemophilus Influenzae Type B Vaccine Market Size by Application
6.2.1 North America Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028)
6.2.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2028)
6.3 North America Haemophilus Influenzae Type B Vaccine Market Size by Country
6.3.1 North America Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2028)
6.3.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Haemophilus Influenzae Type B Vaccine Market Size by Type
7.1.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028)
7.1.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2028)
7.2 Europe Haemophilus Influenzae Type B Vaccine Market Size by Application
7.2.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028)
7.2.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2028)
7.3 Europe Haemophilus Influenzae Type B Vaccine Market Size by Country
7.3.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2028)
7.3.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size by Type
8.1.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size by Application
8.2.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size by Region
8.3.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Haemophilus Influenzae Type B Vaccine Market Size by Type
9.1.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2028)
9.2 Latin America Haemophilus Influenzae Type B Vaccine Market Size by Application
9.2.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2028)
9.3 Latin America Haemophilus Influenzae Type B Vaccine Market Size by Country
9.3.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Type
10.1.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Application
10.2.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Country
10.3.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 Takeda Pharmaceuticals Company
11.5.1 Takeda Pharmaceuticals Company Corporation Information
11.5.2 Takeda Pharmaceuticals Company Overview
11.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Takeda Pharmaceuticals Company Recent Developments
11.6 Walvax Biotechnology
11.6.1 Walvax Biotechnology Corporation Information
11.6.2 Walvax Biotechnology Overview
11.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Walvax Biotechnology Recent Developments
11.7 Lanzhou Institute of Biologica
11.7.1 Lanzhou Institute of Biologica Corporation Information
11.7.2 Lanzhou Institute of Biologica Overview
11.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lanzhou Institute of Biologica Recent Developments
11.8 Immunize BC
11.8.1 Immunize BC Corporation Information
11.8.2 Immunize BC Overview
11.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Immunize BC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Haemophilus Influenzae Type B Vaccine Industry Chain Analysis
12.2 Haemophilus Influenzae Type B Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Haemophilus Influenzae Type B Vaccine Production Mode & Process
12.4 Haemophilus Influenzae Type B Vaccine Sales and Marketing
12.4.1 Haemophilus Influenzae Type B Vaccine Sales Channels
12.4.2 Haemophilus Influenzae Type B Vaccine Distributors
12.5 Haemophilus Influenzae Type B Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Haemophilus Influenzae Type B Vaccine Industry Trends
13.2 Haemophilus Influenzae Type B Vaccine Market Drivers
13.3 Haemophilus Influenzae Type B Vaccine Market Challenges
13.4 Haemophilus Influenzae Type B Vaccine Market Restraints
14 Key Findings in The Global Haemophilus Influenzae Type B Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Liquid Monovalent HIB
Table 3. Major Manufacturers of Liquid Combination HIB
Table 4. Major Manufacturers of Lyophilized Monovalent HIB
Table 5. Major Manufacturers of Lyophilized Combination HIB
Table 6. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2022) & (M Doses)
Table 9. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2017-2022)
Table 10. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2023-2028) & (M Doses)
Table 11. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2023-2028)
Table 12. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2017-2022)
Table 14. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2023-2028)
Table 16. Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (2017-2022) & (M Doses)
Table 17. Global Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturers (2017-2022)
Table 18. Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers (2017-2022)
Table 20. Haemophilus Influenzae Type B Vaccine Price by Manufacturers (2017-2022) &(USD/Dose)
Table 21. Global Haemophilus Influenzae Type B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Haemophilus Influenzae Type B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2021)
Table 23. Haemophilus Influenzae Type B Vaccine Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Haemophilus Influenzae Type B Vaccine Product Offered
Table 25. Date of Manufacturers Enter into Haemophilus Influenzae Type B Vaccine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 28. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses)
Table 29. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2017-2022)
Table 30. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2023-2028)
Table 31. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2017-2022)
Table 34. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2023-2028)
Table 35. Haemophilus Influenzae Type B Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 36. Global Haemophilus Influenzae Type B Vaccine Price Forecast by Type (2023-2028) & (USD/Dose)
Table 37. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 38. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses)
Table 39. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2017-2022)
Table 40. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2023-2028)
Table 41. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2017-2022)
Table 44. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2023-2028)
Table 45. Haemophilus Influenzae Type B Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 46. Global Haemophilus Influenzae Type B Vaccine Price Forecast by Application (2023-2028) & (USD/Dose)
Table 47. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 48. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses)
Table 49. North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 52. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses)
Table 53. North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses)
Table 56. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2023-2028) & (M Doses)
Table 57. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 60. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses)
Table 61. Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 64. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses)
Table 65. Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses)
Table 68. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2023-2028) & (M Doses)
Table 69. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 72. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses)
Table 73. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 76. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses)
Table 77. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2017-2022) & (M Doses)
Table 80. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2023-2028) & (M Doses)
Table 81. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 84. Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses)
Table 85. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 88. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses)
Table 89. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses)
Table 92. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2023-2028) & (M Doses)
Table 93. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2022) & (M Doses)
Table 96. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2023-2028) & (M Doses)
Table 97. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2022) & (M Doses)
Table 100. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2023-2028) & (M Doses)
Table 101. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2022) & (M Doses)
Table 104. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2023-2028) & (M Doses)
Table 105. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 107. Novartis Corporation Information
Table 108. Novartis Description and Major Businesses
Table 109. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 110. Novartis Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novartis Recent Developments
Table 112. Merck Corporation Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 115. Merck Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. Sanofi Corporation Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 120. Sanofi Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. GlaxoSmithKline Corporation Information
Table 123. GlaxoSmithKline Description and Major Businesses
Table 124. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 125. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. GlaxoSmithKline Recent Developments
Table 127. Takeda Pharmaceuticals Company Corporation Information
Table 128. Takeda Pharmaceuticals Company Description and Major Businesses
Table 129. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 130. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Takeda Pharmaceuticals Company Recent Developments
Table 132. Walvax Biotechnology Corporation Information
Table 133. Walvax Biotechnology Description and Major Businesses
Table 134. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 135. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Walvax Biotechnology Recent Developments
Table 137. Lanzhou Institute of Biologica Corporation Information
Table 138. Lanzhou Institute of Biologica Description and Major Businesses
Table 139. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 140. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Lanzhou Institute of Biologica Recent Developments
Table 142. Immunize BC Corporation Information
Table 143. Immunize BC Description and Major Businesses
Table 144. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 145. Immunize BC Haemophilus Influenzae Type B Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Immunize BC Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Raw Materials Key Suppliers Lists
Table 149. Haemophilus Influenzae Type B Vaccine Distributors List
Table 150. Haemophilus Influenzae Type B Vaccine Customers List
Table 151. Haemophilus Influenzae Type B Vaccine Market Trends
Table 152. Haemophilus Influenzae Type B Vaccine Market Drivers
Table 153. Haemophilus Influenzae Type B Vaccine Market Challenges
Table 154. Haemophilus Influenzae Type B Vaccine Market Restraints
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Haemophilus Influenzae Type B Vaccine Product Picture
Figure 3. Global Haemophilus Influenzae Type B Vaccine Market Share by Type in 2021 & 2028
Figure 3. Liquid Monovalent HIB Product Picture
Figure 4. Liquid Combination HIB Product Picture
Figure 5. Lyophilized Monovalent HIB Product Picture
Figure 6. Lyophilized Combination HIB Product Picture
Figure 7. Global Haemophilus Influenzae Type B Vaccine Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Research Institutions
Figure 10. Pharmaceutical and Biotechnology Companies
Figure 11. Academic Institutions
Figure 12. Other
Figure 13. Haemophilus Influenzae Type B Vaccine Report Years Considered
Figure 14. Global Haemophilus Influenzae Type B Vaccine Sales 2017-2028 (M Doses)
Figure 15. Global Haemophilus Influenzae Type B Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Haemophilus Influenzae Type B Vaccine Revenue 2017-2028 (US$ Million)
Figure 17. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2017-2022)
Figure 19. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2023-2028)
Figure 20. North America Haemophilus Influenzae Type B Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 21. North America Haemophilus Influenzae Type B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Haemophilus Influenzae Type B Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 23. Europe Haemophilus Influenzae Type B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 25. Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Haemophilus Influenzae Type B Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 27. Latin America Haemophilus Influenzae Type B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales YoY (2017-2028) & (M Doses)
Figure 29. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Haemophilus Influ

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cephalosporin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109

Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......

Global Polymixin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......

Global Sepsis Partnering Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78

The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......

Global Cephalosporin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156

According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......

Global Amoxicillin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127

According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......

Global Metronidazole Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136

According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......

Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......

Global Ampicillin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101

According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs